SCHEMBL30835154

SCHEMBL30835154

COc1ccc(CNc2nc(Cl)c(F)c3nc(SC)nc(O)c23)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.40
SRC P12931 1/20 0.40
CCNE2 O96020 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
PRUNE1 Q86TP1 1/20 0.40
POLB P06746 1/20 0.39
EGFR P00533 2/20 0.39
LMNA P02545 2/20 0.38
TP53 P04637 1/20 0.38
PPARG P37231 1/20 0.38
MAP2K4 P45985 1/20 0.38
NPC1 O15118 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
THRB P10828 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
RECQL P46063 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26709323 1.00 ABL1 (0.40) ABL1SRCCCNE2CCNE1CDK2
SCHEMBL30835147 0.91 CCNE2 (0.42) ABL1SRCCCNE2CCNE1CDK2
SCHEMBL31521278 0.77
SCHEMBL29181802 0.77 KDM4E (0.32) POLBLMNAMEN1ALDH1A1MAPT
SCHEMBL25081029 0.75 HTT (0.33) LMNAHTT
SCHEMBL27138690 0.72 L3MBTL1 (0.32) LMNAL3MBTL1MEN1ALDH1A1MAPT
SCHEMBL28561177 0.71 PPARG (0.59) ABL1SRCCCNE2CCNE1CDK2
SCHEMBL25601605 0.70
SCHEMBL30254311 0.70
SCHEMBL31279002 0.68 NPC1 (0.41) ABL1SRCCCNE2CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119790059-A Heterocyclic compounds as KRAS inhibitors, their preparation and therapeutic use 上海科州药物股份有限公司 2025-04-08 CN disclosed
CN-117813306-A Heterocyclic compounds as KRAS inhibitors, their preparation and therapeutic use 上海科州药物研发有限公司 2024-04-02 CN disclosed